SYMPOSIUM
Moderator: P. Boura , Chr. Nikolaou
Type I Interferons in SLE pathogenesis
A. Psarras
Could SLE immune pathophysiology offer reliable biomarkers to solve unmet needs?
I. Gkougkourelas
Targeting complement in systemic lupus erythematosus (SLE): a translational ‘conundrum’ to be solved
D. Mastellos
Machine learning in autoimmune disease/systemic lupus erythematosus. Where are we now?
I. Theodorou